Market requirements meet best practices along the entire Life Sciences value chain
Have you ever wondered why some habits stick and others fall by the wayside?
In the workplace, this difficulty in implementing new habits is the cause of great frustration for leaders and managers. That may be caused by either our own failure to stick to what we know is good practice, or our team members’ struggles to put new learning into practice. In the current ever changing demands of our new working environments this can prove even more challenging.
The Market Access function in pharmaceutical and other medical technology companies has reached a stage of maturity, and professionals now want to take a step back, explore best practices and identify the best approach to innovation.
CEOs and Boards of Directors across the globe are struggling to understand how digitalization, the process of becoming a digital business, can be leveraged to achieve the growth they are seeking. However many of these same leaders are focusing primarily on operational efficiency and wonder why they are not seeing the growth results they desire. European business leaders must understand that expanding and diversifying their business model portfolio plays a significant role in realizing growth. In this report, we explain how to deliver on ambitious growth goals by business model innovation and how to move towards the new value-creative asset-light with a blended business model.